ARCH-allied AN Venture Partners raises $200M to build biotechs out of research from Japan
A new investment firm affiliated with ARCH Venture Partners has raised $200 million for its first fund as it seeks to back scientific research out of Japan to create new global biotech startups.
AN Venture Partners’ financing haul was disclosed in a Thursday SEC filing and comes the same week Osaka-based drugmaker Ono Pharmaceutical said it had doubled its own corporate VC arm to $200 million after having already backed 11 startups, including Photys Therapeutics.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
